An update on the genetic basis of type 2 diabetes

Current Opinion in Endocrinology and Diabetes

Volumn 5, Issue 2, 1998, Pages 116-125

  Elbein, Steven C ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR I;

AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 1; CHROMOSOME 2Q; DNA POLYMORPHISM; GENE LOCUS; HUMAN; INDIAN; INSULIN RELEASE; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SEGREGATION ANALYSIS;

EID: 0031776181     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199804000-00007     Document Type: Review

References (105)

1. Rewers M, Hamman RF: Risk factors for non-insulin-dependent diabetes. In Diabetes in America, edn 2. Edited by the National Diabetes Data Group. Bethesda: National Institutes of Health/NIDDK; 1995:179-220.
2. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin dependent diabetes. In Diabetes in America, edn 2. Edited by the National Diabetes Data Group. Bethesda: National Institutes of Health/NIDDK; 1995:47-68.
3. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 1996, 47:509-531.
4. Elbein SC, Hoffman M, Ridinger D, Otterud B, Leppert M: Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase locus in familial NIDDM. Diabetes 1994, 43:1061-1065.
5. McCarthy MI, Hitman GA, Shields DC, Morton NE, Snehalatha C, Mohan V, Ramachandran A, Viswanathan M: Family studies of non-insulin-dependent diabetes mellitus in South Indians. Diabetologia 1994, 37:1221-1230.
6. Hanson RL, Elston RC, Pettitt DJ, Bennett PH, Knowler WC: Segregation analysis of non-insulin-dependent diabetes mellitus in Pima Indians: evidence for a major-gene effect. Am J Hum Genet 1995, 57:160-170.
7. Stern MP, Mitchell BD, Blangero J, Reinhart L, Krammerer CM, Harrison CR, Shipman PA, O'Connell P, Frazier ML, MacCluer JW, et al.: Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 1996, 45:563-568. Segregation analysis of type 2 diabetes in a Hispanic population.
8. Bell GI, Xiang K, Newman MV, Xiang KS, Wu SH, Wright LG, Fajans SS, Spielman RS, Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A 1991, 88:1884-1888.
9. Bowden DW, Akots G, Rothschild CB, Falls KF, Sheehy MJ, Hayward C, Mackie A, Baird J, Brock D, Antonarakis SE, Fajans SS: Linkage analysis of maturity-onset diabetes of the young (MODY): genetic heterogeneity and nonpenetrance. Am J Hum Genet 1992, 50:607-618.
10. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, et al.: Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus [see comments]. N Engl J Med 1993, 328:697-702.
11. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 1995, 9:418-423.
12. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Velho G, Froguel P, et al.: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 1996, 45:1503-1510. Physiologic studies of the MODY3IHNF1α mutation.
13. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj W, et al.: Mutations in the hepatocyte nuclear factor 1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384:455-458. A key breakthrough in the genetics of type 2 diabetes.
14. Iwasaki N, Oda N, Ogata M, Hara M, Hinokio Y, Oda Y, Yamagata K, Kanematsu S, Ohgawara H, Omori Y, Bell GI: Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early and late- onset NIDDM. Diabetes 1997, 46:1504-1508. One of the first studies of HNF1α mutations in Japanese patients.
15. Frayling TM, Bulman MP, Ellard S, Appleton M, Dronsfield MJ, Mackie ADR, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, et al.: Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity onset diabetes of the young in the U.K. Diabetes 1997, 46:720-725. One of the initial studies of HNF1α mutations in Caucasians.
16. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj VV, Chevre JC, Boccio V, Cox RD, Lathrop GM, et al.: Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity onset diabetes of the young (MODY3). Hum Mol Genet 1997, 6:583-586.
17. Glucksmann MA, Lehto M, Tayber O, Scotti S, Berkemeier L, Pulido JC, Wu Y, Nir WJ, Fang L, Markel P, et al.: Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 1997, 46:1081-1086. An important study showing the frequency of HNF1α mutations and reporting the common exon 4 mutation.
18. Kaisaki PJ, Menzel R, Linder T, Oda N, Rjasanowski I, Sahm J, Meincke G, Schulze J, Schmecnel H, Petzold C, et al.: Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 1997, 46:528-535. This study suggests that HNF1α mutations may be common in early-onset diabetes.
19. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Moller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, et al.: Novel MODY3 mutations in the hepatocyte nuclear factor-1 alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 1997, 46:726-730.
20. Froguel P: Glucokinase and MODY: from the gene to the disease. Diabet Med 1996, 13:S96-S97.
21. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384:458-460. The second key breakthrough in genetics of type 2 diabetes, although mutations of the MODY1 gene are rare.
22. Furuta H, Iwasaki N, Oda N, Hinokio Y, Horikawa Y, Yamagata K, Yano H, Sugahiro J, Ogata M, Ohgawara H, et al.: Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 1997, 46:1652-1657.
23. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI: Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4α binding site in the promoter of the hepatocyte nuclear factor-1α gene. Diabetes 1997, 46:1648-1651. A study that shows the importance of the HNF pathway in diabetes pathogenesis.
24. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockbum BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, et al.: Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet 1997, 17:384-385. A novel mutation in yet another member of the HNF pathway causing diabetes.
25. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997, 17:138-139. A fifth MODY gene in another factor that leads to a defect in insulin secretion.
26. Warram JH, Martin BC, Krolewski AS: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990, 113:909-915.
27. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS: Familial clustering of insulin sensitivity. Diabetes 1992, 41:850-854.
28. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992, 15:318-368.
29. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, et al.: Mapping a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996, 14:90-94. Report of a potential susceptibility locus near MODY3.
30. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, Freedman BI: Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997, 46:882-886.
31. Urhammer SA, Rasmussen SK, Kaisaki PJ, Oda N, Yamagata K, Moller AM, Fridberg M, Hansen L, Hansen T, Bell GI, et al.: Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM. Diabetologia 1997, 40:473-475.
32. Urhammer SA, Fridberg M, Hansen T, Rasmussen SK, Moller AM, Clausen JO, Pedersen O: A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1 alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 1997, 46:912-916.
33. Yamada S, Nishigori H, Onda H, Takahashi K, Kitano N, Morikawa A, Takeuchi T, Takeda J: Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of late-onset NIDDM in Japanese subjects. Diabetes 1997, 46:1512-1513.
34. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, et al.: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994, 330:962-968.
35. Elbein SC, Hoffman MD: Role of mitochondrial DNA tRNA leucine and glucagon receptor missense mutations in Utah white diabetic patients. Diabetes Care 1996, 19:507-508.
36. Sepehrnia B, Prezant TR, Rotter JI, Pettitt DJ, Knowler WC, Fischel Ghodsian N: Screening for mtDNA diabetes mutations in Pima Indians with NIDDM. Am J Med Genet 1995, 56:198-202.
37. Dussoix P, Vaxillaire M, lynedjian PB, Tiercy J M, Ruiz J, Sinas GA, Berger W, Zahnd G, Froguel P, Philippe J, et al.: Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters. Diabetes 1997, 46:622-631.
38. Leu(UUR) mutation at position 3243 in UK Caucasian type 2 diabetic patients. Diabet Med 1997, 14:42-45.
39. Newkirk JE, Taylor RW, Howell N, Bindoff LA, Chinnery PF, Alberti KGMM, Turnbull DM, Walker M: Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population. Diabet Med 1997, 14:457-460.
40. Nakamura M, Varga House D, Winter W: A novel homoplasmic point mutation at mitochondrial DNA (mtDNA) nucleotide 3308 in a family with atypical diabetes mellitus (ADM) of African Americans [abstract]. Diabetes 1997, 46(suppl 1):175A.
41. Anderson C, Herrnstadt C, Miller S, Olefsky J, Davis R: Mutations in mitochondrial ATP synthase 8 gene are associated with NIDDM [abstract]. Diabetes 1997, 46(suppl 1):174A.
42. Permutt MA, Elbein SC: Insulin gene in diabetes: analysis through RFLP. Diabetes Care 1990, 13:364-374.
43. Elbein SC, Hoffman MD, Bragg KL, Mayorga RA: The genetics of NIDDM: an update. Diabetes Care 1994, 17:1523-1533.
44. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Metab Rev 1997, 5:177-220. A comprehensive review of the pathophysiologic defects that precede type 2 diabetes and are probably inherited.
45. Elbein SC, Hoffman MD, Mayorga RA, Barrett KL, Leppert M, Hasstedt S: Do NIDDM and IDDM share genetic susceptibility loci? An analysis of putative IDDM susceptibility regions in familial NIDDM. Metabolism 1997, 46:48-52.
46. Elbein SC, Chiu KC, Hoffman MD, Mayorga RA, Bragg KL, Leppert MF: Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 1995, 44:1259-1265.
47. Vionnet N, Hani EH, Lesage S, Philippi A, Hager J, Varret M, Stoffel M, Tanizawa Y, Chiu KC, Glaser B, et al.: Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes 1997, 46:1062-1068.
48. Majer M, Mott DM, Mochizuki H, Rowles JC, Pedersen O, Knowler WC, Bogardus C, Prochazka M: Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians. Diabetologia 1996, 39:314-321.
49. Hani EH, Zouali H, Philippi A, Beaudoin JC, Vionnet N, Passa P, Demenais F, Froguel P: Indication for genetic linkage of the phosphoenolpyruvate carboxykinase (PCK1) gene region on chromosome 20q to non-insulin-dependent diabetes mellitus. Diabetes Metab 1996, 22:451-454.
50. Taylor RW, Printz RL, Armstrong M, Granner DK, Alberti KGMM, Turnbull DM, Walker M: Variant sequences of the hexokinase II gene in familial NIDDM. Diabetologia 1996, 39:322-328.
51. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, et al.: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996, 13:161-166. Despite its lack of duplication, this study presents an important breakthrough in the search for diabetes susceptibility genes.
52. Orho M, Carlsson M, Kanninen T, Groop LC: Polymorphism at the red gene is not associated with NIDDM in Finns. Diabetes 1996, 45:429-433.
53. Doria A, Caldwell JS, Ji L, Reynet C, Rich SS, Weremowicz S, Morton CC, Warram JH, Kahn CR, Krolewski AS: Trinucleotide repeats at the rad locus: allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q. Diabetes 1995, 44:243-247.
54. Reynet C, Kahn CR: Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993, 262:1441-1444.
55. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O: Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993, 342:828-832.
56. Zhang Y, Wat N, Stratton IM, Warren-Perry MG, Orho M, Groop L, Turner RC: UKPDS 19: Heterogeneity in NIDDM: separate contributions of IRS-1 and β3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase mutations: UK Prospective Diabetes Study. Diabetologia 1996, 39:1505-1511.
57. Ura S, Araki E, Kishikawa H, Shirotani T, Todaka M, Isami S, Shimoda S, Yoshimura R, Matsuda K, Motoyoshi S, et al.: Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms. Diabetologia 1996, 39:600-608.
58. Yoshimura R, Araki E, Ura S, Todaka M, Tsuruzoe K, Furukawa N, Motoshima H, Yoshizato K, Kaneko K, Matsuda K, et al.: Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in Impaired function at different steps of IRS-1 signalling. Diabetes 1997, 46:929-936.
59. Almind K, Inoue G, Pedersen O, Kahn CR: A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling: evidence from transfection studies. J Clin Invest 1996, 97:2569-2575.
60. Krook A, Moller DE, Dib K, O'Rahilly SP: Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin: evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J Biol Chem 1996, 271:7134-7140.
61. Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 1996, 271:10892-10896.
62. Rissanen J, Pihlajamaki J, Heikkinen S, Kekalainen P, Kuusisto J, Laakso M: The Ala54Thr polymorphism of fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes 1997, 46:711-712.
63. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, et al.: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995, 333:343-347.
64. Clement K, Vaisse C, Manning BS, Basdevant A, Guy Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, et al.: Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995, 333:352-354.
65. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC: Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995, 333:348-351.
66. Mauriege P, Bouchard C: Trp64Arg mutation in β3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 1996, 348:698-699.
67. Elbein SC, Hoffman M, Barrett K, Wegner K, Miles C, Bachman K, Berkowitz D, Shuldiner AR, Leppert MF, Hasstedt S: Role of the beta 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996, 81:4422-4427.
68. Silver K, Walston J, Wang Y, Dowse G, Zimmet P, Shuldiner AR: Molecular scanning for mutations in the beta 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996, 81:4155-4158.
69. Urhammer SA, Clausen JO, Hansen T, Pedersen O: Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes 1996, 45:1115-1120.
70. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Oga T, Ueda H, Shintani M, Fukuda M, et al.: Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996, 39:349-352.
71. 3 adrenergic receptor locus on obesity in Mexican Americans [abstract]. Diabetes 1997, 46(suppl 1):170A.
72. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J: A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997, 15:273-275.
73. Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, Kumagaye KY, Nakajima K, Nanjo K: Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996, 45:1279-1281.
74. Ferrer J, Aoki M, Behn P, Nestorowicz A, Riggs A, Permutt MA: Mitochondrial glycerol-3-phosphate dehydrogenase: cloning of an alternatively spliced human islet-cell cDNA, tissue distribution, physical mapping, and identification of a polymorphic genetic marker. Diabetes 1996, 45:262-266.
75. + channel: no evidence for linkage in maturity onset diabetes of the young or NIDDM. Diabetes 1996, 45:639-641.
76. MacDonald MJ, Brown J, Hasan NM, Stoffel M, Dills DG: Single stranded conformation polymorphism analysis of the mitochondrial glycerol phosphate dehydrogenase gene in NIDDM. Diabetes 1997, 46:1660-1661.
77. Novalis A, Vidai J, Franco C, Ribera F, Sener A, Malaisse WJ, Gomis R: Mutation in the calcium-binding domain of the mitochondrial glycerophosphate dehydrogenase gene in a family of diabetic subjects. Biochem Biophys Res Commun 1997, 231:570-572.
78. Takeuchi Y, Matsutani A, Oka Y: Detection of variants in the mitochondrial glycerophosphate dehydrogenase gene in Japanese NIDDM patients. Diabetologia 1997, 40:339-343.
79. Stone LM, Kahn SE, Deeb SS, Fujimoto WY, Porte Jr D: Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Diabetes Care 1994, 17:1480-1483.
80. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte Jr D: A variation at position -30 of the β-cell glucokinase gene promoter polymorphism is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes 1996, 45:422-428.
81. Zaidi FK, Wareham NJ, McCarthy MI, Holdstock J, Kalloo-Hosein H, Krook A, Swinn RA, O'Rahilly SP: Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women. Diabet Med 1997, 14:228-234.
82. Chiu KC, McCarthy JE: Promoter variation in liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1996, 221:614-618.
83. Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R, Warren-Perry M, Zhang Y, Millns H, Turner R, et al.: Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996, 45:825-831. First report of an association of a variant in the sulfonylurea receptor gene with type 2 diabetes in two populations.
84. Iwasaki N, Kawamura M, Yamagata K, Cox NJ, Karibe S, Ohgawara H, Inagaki N, Seino S, Bell GI, Omori Y: Identification of microsatellite markers near the human genes encoding the beta-cell ATP-sensitive K+ channel and linkage studies with NIDDM in Japanese. Diabetes 1996, 45:267-269.
85. Hani EH, Clement K, Velho G, Vionnet N, Hager J, Philippi A, Dina C, Inoue H, Permutt MA, Basdevant A, et al.: Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French caucasians. Diabetes 1997, 46:688-694. A study confirming and extending the findings of the earlier report of an association of the sulfonylurea receptor gene with type 2 diabetes.
86. Stirling B, Cox NJ, Bell GI, Hams CL, Spielman RS, Concannon P: Linkage studies in NIDDM with markers near the sulphonylurea receptor gene. Diabetologia 1995, 38:1479-1481.
87. Lindner T, Gragnoli C, Schulze J, Rietzsch H, Petzold C, Schroeder H-E, Cox NJ, Bell GI: The 31-cM region of chromosome 11 including the obesity gene Tubby and ATP-sensitive potassium channel genes, SUR1 and KIR6.2, does not contain a major susceptibility locus for NIDDM in 127 non-hispanic white affected sibships. Diabetes 1997, 46:1227-1229.
88. Elbein SC, Bragg KL, Hoffman MD, Mayorga RA, Leppert ML: Linkage studies of NIDDM with 23 chromosome 11 markers in a sample of whites of Northern European descent. Diabetes 1996, 45:370-375.
89. Inoue H, Ferrer J, Elbein SC, Warren-Perry M, Zhang Y, Millns H, Turner R, Suarez B, Seino S, Permutt MA: Sequence variants in the pancreatic islet β-cell ATP regulatable inward rectifier gene Kir6.2: analysis in caucasian patients with non-insulin dependent diabetes mellitus (NIDDM). Diabetes 1997, 47:502-507.
90. Yoshida H, Ohagi S, Sanke T, Furuta H, Furuta M, Nanjo K: Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes 1995, 44:389-393.
91. Ohagi S, Sakaguchi H, Sanke T, Tatsuta H, Hanabusa T, Nanjo K: Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes 1996, 45:897-901.
92. Kalidas K, Dow E, Saker P, Walker M, Wareham N, Halsall D, O'Rahilly S, McCarthy M, Johnston D: Genetic analysis of PC3 gene in relation to hyperproinsulinemla and NIDDM [abstract]. Diabetes 1997, 46(suppl 1):178A.
93. Stern MP, Duggirala R, Mitchell BD, Reinhart LJ, Shivakumar S, Shipman PA, Uresandi OC, Benavides E, Blangero J, O'Connell P: Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 1996, 6:724-734. A partial genome scan using quantitative traits showing linkage near the SUR locus.
94. Elbein SC, Hoffman M, Leppert M, Hasstedt S: Linkage of fasting glucose in relatives of an NIDDM sib pair to markers on chromosome 9p [abstract]. Diabetes 1997, 46(suppl 1):51A.
95. Pratley R, Thompson DB, Prochazka M, Baier LJ, Pima Diabetes Gene Group: A genome scan for linkage to quantitative traits predicting NIDDM in Pima Indians [abstract]. Diabetes 1997, 46(suppl 1):170A.
96. Kruglyak L, Lander ES: Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet 1995, 57:439-454.
97. Hanson R, The Pima Diabetes Group: Genomic scan for markers linked to type II diabetes in Pima Indians [abstract]. Diabetes 1997, 46(suppl 1):51A.
98. McCarthy M, Cassell P, Saker P, Armstrong M, Turner R, O'Rahilly S, Walker M, Hattersley A, Hitman G: No excess allele-sharing on chromosome 2q (region of NIDDMI) in a large European sibship collection [abstract]. Diabetes 1997, 46(suppl 1):52A.
99. Hani EH, Hager J, Philippi A, Demenais F, Froguel P, Vionnet N: Mapping NIDDM susceptibility loci in French families: studies with markers in the region of NIDDM1 on chromosome 2q. Diabetes 1997, 46:1225-1226.
100. Lesage S, Hani EH, Philippi A, Vaxillaire M, Hager J, Passa P, Demenais F, Froguel P, Vionnet N: Linkage analyses of the MODY3 locus on chromosome 12q with late-onset NIDDM. Diabetes 1995, 44:1243-1247.
101. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247.
102. Ghosh S, Hauser E, Magnuson V, Valle T, Ally D, Watanabe R, Hagopian W, Bergman R, Tuomilehto J, Collins F, et al.: The FUSION (Finland-United States Investigation of NIDDM Genetics) Study [abstract]. Am J Hum Genet 1997, 61(suppl):A276.
103. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, Froguel P: A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 1997, 6:1401-1408. One of several studies showing linkage on chromosome 20, albeit not at significant levels that are widely accepted.
104. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS: New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997, 46:876-881.
105. Raffel LJ, Robbins DC, Norris JM, Boerwinkle E, DeFronzo RA, Elbein SC, Fujimoto W, Hanis CL, Kahn SE, Mulivor R, et al.: The GENNID study: a resource for mapping the genes causing noninsulin-dependent-diabetes mellitus. Diabetes Care 1996, 19:864-872.